Quick Answer
Propanc Biopharma, Inc. reported Common Stock Shares Outstanding of 11.61 million shares for the year ending 2025.
- Propanc Biopharma, Inc. showed an increase of +145,411.1% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Propanc Biopharma, Inc.'s annual report (Form 10-K), filed with the SEC on September 29, 2025.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 15 years of available data (2011 to 2025), Propanc Biopharma, Inc.'s Common Stock Shares Outstanding has declined by 83.9%.
- Historical annual values: Fiscal year 2025: 11.61 million shares | Fiscal year 2024: 7,980 shares | Fiscal year 2023: 6.03 million shares | Fiscal year 2022: 220,351 shares | Fiscal year 2021: 14.06 million shares | Fiscal year 2020: 258,120 shares | Fiscal year 2019: 967,993 shares | Fiscal year 2018: 92,810 shares | Fiscal year 2017: 4.55 million shares | Fiscal year 2016: 2.91 million shares | Fiscal year 2015: 347.44 million shares | Fiscal year 2014: 72.68 million shares | Fiscal year 2013: 70.63 million shares | Fiscal year 2012: 72.71 million shares | Fiscal year 2011: 71.92 million shares.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: